Dystrophin and metalloproteinase 9 in myocardial ischemia: A post-mortem immunohistochemical study

Area of Science:

• Cardiovascular Pathology
• Forensic Pathology
• Biomarker Research

Background:

• Coronary atherosclerotic disease (CAD) is a leading cause of sudden cardiac death (SCD).
• Accurate post-mortem diagnosis of myocardial ischemia is crucial in forensic investigations.
• The expression patterns of specific proteins during ischemia are not fully elucidated.

Purpose of the Study:

• To evaluate dystrophin and MMP-9 expression in SCD cases related to CAD.
• To analyze the chronological expression of these proteins for diagnostic utility.
• To compare dystrophin and MMP-9 expression with C5b-9 complex and fibronectin.

Main Methods:

• Immunohistochemical staining was performed on myocardial tissue samples.
• Samples were categorized into two groups based on histological evidence of ischemia and a control group.
• Expression levels of dystrophin, MMP-9, C5b-9, and fibronectin were assessed.

Main Results:

• Dystrophin and MMP-9 exhibited distinct expression patterns between groups with and without histological signs of ischemia.
• Group 1 showed sarcolemmal staining depletion for dystrophin and increased interstitial/granulocyte positivity for MMP-9.
• Loss of dystrophin staining and C5b-9 positivity were more pronounced than MMP-9 increases.

Conclusions:

• Dystrophin and MMP-9 are potential immunohistochemical markers for detecting myocardial ischemic damage.
• Loss of dystrophin expression may serve as an earlier marker of myocardial ischemia compared to MMP-9.
• These findings can aid in the post-mortem diagnosis of myocardial ischemia in SCD cases.